-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Most Recent News
Argenx announced today that it had spent $2.2 billion, or $77 per share in a cash tender offer to acquire… READ MORE
Eli Lilly announced today that it was able to achieve positive results from two of its pivotal phase 3 studies… READ MORE
Summit Therapeutics today provided updated overall survival data from its phase 3 HARMONi study using its PD-1/VEGF bispecific antibody inhibitor… READ MORE
Things did not go well for Agios Pharmaceuticals today because it noted that it would no longer develop its next-generation… READ MORE
Things went well this week for Merck, as on July 16, 2026, it was able to receive FDA approval of… READ MORE
Eli Lilly today entered into an agreement for $2.8 billion to acquire AtaiBeckley. The main reason for this big pharma… READ MORE
Cecluity was able to have a monumental day the other day on Tuesday, July 14, 2026, as it was able… READ MORE
Spero Therapeutics announced today that it entered into a license agreement with Innovent Biologics so that it could in-license a… READ MORE
"People ask me what I do in the winter when there's no baseball. I'll tell you what I do. I stare out the window and wait for spring."
~ Rogers Hornsby
This website Biopharmatpnews.com is a website about learning the latest news in biotech. It deals with big pharma, biotechs, and other pharmaceutical news. This is your one true source to top point news in the biotech industry. From the science, clinical trials, catalysts and many others, everyone can learn something new in this industry .
BiopharmaTPnews 